IL-15 and Psoriasis: Another Genetic Link to Th17?
- 1 November 2007
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (11), 2495-2497
- https://doi.org/10.1038/sj.jid.5700855
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of PsoriasisNew England Journal of Medicine, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesAmerican Journal of Human Genetics, 2007
- The IL-23/IL-17 axis in inflammationJCI Insight, 2006
- Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 GeneAmerican Journal of Human Genetics, 2006
- Divergent effects of IL‐12 and IL‐23 on the production of IL‐17 by human T cellsEuropean Journal of Immunology, 2006
- Systematic Linkage Disequilibrium Analysis of SLC12A8 at PSORS5 Confirms a Role in Susceptibility to Psoriasis VulgarisJournal of Investigative Dermatology, 2005
- Interleukin-15: a new cytokine target for the treatment of inflammatory diseasesCurrent Opinion in Pharmacology, 2004
- Meta-Analysis of Genome-Wide Studies of Psoriasis Susceptibility Reveals Linkage to Chromosomes 6p21 and 4q28–q31 in Caucasian and Chinese Hans PopulationJournal of Investigative Dermatology, 2004
- Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgarisJournal of Dermatological Science, 2002
- The Future of Genetic Studies of Complex Human DiseasesScience, 1996